A few observational reports havent shown major birth defects, but the sample sizes are small, and research is still ongoing
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study
Symptoms Patients Should Ask About If taking semaglutide, the prescribing healthcare provider may offer regular check-ins to monitor progress, note any side effects, and assess the risk level for known safety concerns, including medullary thyroid cancer
A meta-analysis of GLP-1 safety data found no causal link established between the drug class and appendicitis development, though individual case reports have prompted investigation into potential mechanisms
Bottom Line Semaglutide and tirzepatide are both evidence-based options for chronic weight management, but the best fit depends on the person
If you are pregnant, breastfeeding, or have any medical conditions, consult your healthcare provider before using this product